Gilead Sciences filed a trademark application on March 26 to protect the design of a drug bottle that would be used for coronavirus treatment. The filing suggests that the pharmaceutical company could be anticipating the release of a product soon.

Josh Gerben was quoted Axios discussing why a company would trademark its packaging:

“The reason you make this trademark is because you think you’re going to get a product out there soon.”

“This is part of your brand protection.”

Source: Herman, Bob. “Gilead has filed for a trademark on the bottle for a coronavirus drug.” Axios.com. 15 April 2020.